Stay updated on Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.

Latest updates to the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page
- Check3 days agoChange DetectedNew revision notice added: Revision: v3.3.3, and Revision: v3.3.2 removed, along with deletion of the HHS Vulnerability Disclosure link in the footer; these are routine maintenance updates that do not affect study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded Revision: v3.3.2 and removed Revision: v3.2.0 from the page. This is a site-version update and does not modify study details or historical records.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the banner notice about a lapse in government funding and operating status information from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedNew screenshots show administrative updates to the record history, including additional version entries and status changes, plus added sections like IPDSharing and Contacts/Locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference9%

- Check89 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.2%

Stay in the know with updates to Lomvastomig in Solid Tumors Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lomvastomig in Solid Tumors Dose Escalation Clinical Trial page.